Datavault AI Enters Agreement with Wellgistics Health, Asset Value Approximately $4 Billion
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Datavault AI (DVLT) entered into a fully binding term sheet with Wellgistics Health (WGRX), integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx into its PharmacyChain, to build Wellgistics into DelivMeds AI following the completion of three concurrent transactions: 1) the expansion of Datavault AI's previously disclosed PharmacyChain license to include Healthcare-as-a-Service-related intellectual property; 2) the acquisition of the QOLPOM intellectual property from EOS Technology Holdings and Scilex Holding Company (SCLX) that enables wearables-driven biometric confirmation of pharmacodynamic drug effect and biometric confirmation named-patient to receive home drug delivery; and 3) the acquisition of a controlling stake in Tollo Health. Together, the three transactions forming DelivMeds carry an expected approximate combined asset value of $4 billion, subject to an independent fairness opinion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DVLT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DVLT
Wall Street analysts forecast DVLT stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.418
Low
4.00
Averages
4.00
High
4.00
Current: 0.418
Low
4.00
Averages
4.00
High
4.00
About DVLT
Datavault AI Inc., formerly WiSA Technologies Inc., is a technology licensing company. The Company's offerings are its artificial intelligence (AI)-driven agents branded as Data Vault, DataValue, DataScore, and Data Vault Bank. It operates through two synergistic platforms: Data Science and Acoustic Science. The Data Sciences division develops and operates tools for the capture, processing, and compliant monetization of data. The division is also focused on the delivery of cyber-secure, privacy protected data management and monetization technologies. Its flagship information data exchange (IDE) is a patented Web 3.0 platform. The Acoustic Sciences Platform features a fusion of WiSA's wireless standard technology and the category creating ADIO inaudible tone, data over sound, and mobile quick response technology. Acoustic Sciences also includes a fusion of its multi-patented, spatial, multichannel, HD wireless sound transmission WiSA HT and WiSA E technologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Formation of DelivMeds AI with Approximate Asset Value of $4 Billion
- Asset Value: The formation of DelivMeds AI is expected to have an approximate asset value of $4 billion, stemming from a comprehensive partnership between Datavault AI and Wellgistics Health aimed at enhancing healthcare service efficiency through blockchain and AI integration, thereby securing a competitive edge in the rapidly evolving healthcare market.
- Technology Integration and Expansion: The fully binding term sheet signed between Datavault AI and Wellgistics Health expands the PharmacyChain™ platform to include Healthcare-as-a-Service (HaaS), connecting over 6,500 pharmacies and 200 manufacturers, significantly improving the efficiency and transparency of pharmaceutical delivery.
- Innovative Healthcare Solutions: Following the acquisition of the QOLPOM patent portfolio, DelivMeds AI will leverage biometric verification and AI-driven drones to enhance pharmaceutical delivery and sample collection in rural areas, which is expected to greatly improve accessibility and compliance in healthcare services.
- Market Promotion and Collaboration: The
See More
Datavault AI Q1 2026 Earnings Call Highlights
- Revenue Target Unchanged: Datavault AI's Chairman and CFO Brett Moyer stated that the 2026 revenue target of $200 million remains unchanged, although it is expected to be more heavily weighted towards the second half of the year, reflecting the company's confidence in future earnings.
- Significant Contract Value: The company signed $800 million in tokenization contracts during the quarter, which are expected to generate approximately $90 million in fees, establishing a robust foundation for future revenue growth.
- Accelerated Financing Plan: Datavault AI announced the execution of a $120 million nondilutive financing agreement to expedite the nationwide rollout of the SanQtum platform, enhancing its competitive position in the market and supporting business expansion.
- Upcoming Exchange Launch: The company plans to launch its exchanges in July, with management emphasizing that this timing is closely tied to the passage of the CLARITY Act, which is expected to make July the biggest revenue month in the company's history, demonstrating a keen awareness of market opportunities.
See More
DataVault's Q1 Results Disappoint, Stock Continues Downward Trend
- Disappointing Performance: DataVault reported a Q1 GAAP EPS loss of $0.09, missing estimates by $0.01, and despite a remarkable 443% YoY revenue growth to $3.42 million, it fell short of expectations by nearly $16.6 million, undermining investor confidence.
- Stock Price Decline: The company's stock has dropped nearly 24% over the past month, falling another ~10% on Friday to around $0.53, resulting in a YTD return of -19.78%, significantly lagging behind the S&P 500's 9.59% gain.
- Long-Term Growth Potential: Despite the short-term setbacks, DataVault AI demonstrated strong momentum in its tokenization business, signing contracts exceeding $800 million, expected to generate nearly $100 million in fees by 2026, indicating future growth prospects.
- Funding and Strategic Plans: The company reiterated its FY26 revenue target of at least $200 million while strengthening its balance sheet through a $60 million stock offering and securing an additional $120 million in non-dilutive funding to support its SanQtum AI infrastructure rollout.
See More
Datavault AI Reports 443% Revenue Surge in Q1 but Misses Expectations
- Significant Revenue Growth: Datavault AI reported a revenue of $3.4 million in Q1, soaring 443% from $0.63 million a year ago, yet it fell short of Wall Street's expectation of $20 million, indicating cautious market sentiment regarding its growth potential.
- Improved Loss Per Share: The company reported an adjusted loss per share of $0.09, an improvement from a loss of $0.18 per share during the same period last year, suggesting progress in cost control and operational efficiency.
- Contract Signings Validate Demand: The signing of approximately $750 million in tokenization contracts during the first quarter reflects growing institutional demand for a secure, AI-enabled real-world asset monetization platform, potentially laying the groundwork for future revenue growth.
- Stock Price Volatility: Despite the substantial revenue increase, Datavault AI's shares fell nearly 11% in pre-market trading on Friday, reflecting investor disappointment over the company's failure to meet expectations.
See More
Datavault AI Q1 Earnings Miss Expectations with Revenue Shortfall
- Earnings Report Disappointment: Datavault AI's Q1 GAAP EPS of -$0.09 misses expectations by $0.01, indicating challenges in profitability that could undermine investor confidence.
- Significant Revenue Growth: Despite a remarkable 442.9% year-over-year revenue increase to $3.42M, the figure fell short of market expectations by $16.58M, highlighting difficulties in expanding market share.
- Future Revenue Target: Datavault AI reiterates its $200 million revenue target for full-year 2026, which aligns with market consensus; however, the feasibility of achieving this goal remains uncertain given current financial performance.
- Market Reaction Anticipation: The earnings miss may lead investors to question the company's future growth potential, particularly in light of its plans to acquire CyberCatch to enhance cybersecurity capabilities.
See More
Datavault AI to Announce Q1 Earnings on May 15
- Earnings Announcement: Datavault AI is set to release its Q1 earnings on May 15 before market open, with a consensus EPS estimate of -$0.08, reflecting a 55.6% year-over-year improvement, indicating potential for enhanced profitability.
- Revenue Surge Expected: The company anticipates Q1 revenue of $20 million, representing a staggering 3074.6% year-over-year increase, which highlights Datavault AI's strong performance in market demand and product acceptance.
- Positive Market Sentiment: As the earnings report approaches, investor interest in Datavault AI is rising, likely leading to stock price volatility, especially after the company raised its revenue guidance, boosting market confidence in its future growth.
- Strategic Acquisition: Datavault AI plans to acquire CyberCatch in an all-stock deal to strengthen its capabilities in AI and quantum-resistant cybersecurity, a move that not only expands its product line but also enhances the company's competitive position in the market.
See More
Formation of DelivMeds AI with Approximate Asset Value of $4 Billion
- Asset Value: The formation of DelivMeds AI is expected to have an approximate asset value of $4 billion, stemming from a comprehensive partnership between Datavault AI and Wellgistics Health aimed at enhancing healthcare service efficiency through blockchain and AI integration, thereby securing a competitive edge in the rapidly evolving healthcare market.
- Technology Integration and Expansion: The fully binding term sheet signed between Datavault AI and Wellgistics Health expands the PharmacyChain™ platform to include Healthcare-as-a-Service (HaaS), connecting over 6,500 pharmacies and 200 manufacturers, significantly improving the efficiency and transparency of pharmaceutical delivery.
- Innovative Healthcare Solutions: Following the acquisition of the QOLPOM patent portfolio, DelivMeds AI will leverage biometric verification and AI-driven drones to enhance pharmaceutical delivery and sample collection in rural areas, which is expected to greatly improve accessibility and compliance in healthcare services.
- Market Promotion and Collaboration: The
See More
Datavault AI Q1 2026 Earnings Call Highlights
- Revenue Target Unchanged: Datavault AI's Chairman and CFO Brett Moyer stated that the 2026 revenue target of $200 million remains unchanged, although it is expected to be more heavily weighted towards the second half of the year, reflecting the company's confidence in future earnings.
- Significant Contract Value: The company signed $800 million in tokenization contracts during the quarter, which are expected to generate approximately $90 million in fees, establishing a robust foundation for future revenue growth.
- Accelerated Financing Plan: Datavault AI announced the execution of a $120 million nondilutive financing agreement to expedite the nationwide rollout of the SanQtum platform, enhancing its competitive position in the market and supporting business expansion.
- Upcoming Exchange Launch: The company plans to launch its exchanges in July, with management emphasizing that this timing is closely tied to the passage of the CLARITY Act, which is expected to make July the biggest revenue month in the company's history, demonstrating a keen awareness of market opportunities.
See More
DataVault's Q1 Results Disappoint, Stock Continues Downward Trend
- Disappointing Performance: DataVault reported a Q1 GAAP EPS loss of $0.09, missing estimates by $0.01, and despite a remarkable 443% YoY revenue growth to $3.42 million, it fell short of expectations by nearly $16.6 million, undermining investor confidence.
- Stock Price Decline: The company's stock has dropped nearly 24% over the past month, falling another ~10% on Friday to around $0.53, resulting in a YTD return of -19.78%, significantly lagging behind the S&P 500's 9.59% gain.
- Long-Term Growth Potential: Despite the short-term setbacks, DataVault AI demonstrated strong momentum in its tokenization business, signing contracts exceeding $800 million, expected to generate nearly $100 million in fees by 2026, indicating future growth prospects.
- Funding and Strategic Plans: The company reiterated its FY26 revenue target of at least $200 million while strengthening its balance sheet through a $60 million stock offering and securing an additional $120 million in non-dilutive funding to support its SanQtum AI infrastructure rollout.
See More
Datavault AI Reports 443% Revenue Surge in Q1 but Misses Expectations
- Significant Revenue Growth: Datavault AI reported a revenue of $3.4 million in Q1, soaring 443% from $0.63 million a year ago, yet it fell short of Wall Street's expectation of $20 million, indicating cautious market sentiment regarding its growth potential.
- Improved Loss Per Share: The company reported an adjusted loss per share of $0.09, an improvement from a loss of $0.18 per share during the same period last year, suggesting progress in cost control and operational efficiency.
- Contract Signings Validate Demand: The signing of approximately $750 million in tokenization contracts during the first quarter reflects growing institutional demand for a secure, AI-enabled real-world asset monetization platform, potentially laying the groundwork for future revenue growth.
- Stock Price Volatility: Despite the substantial revenue increase, Datavault AI's shares fell nearly 11% in pre-market trading on Friday, reflecting investor disappointment over the company's failure to meet expectations.
See More
Datavault AI Q1 Earnings Miss Expectations with Revenue Shortfall
- Earnings Report Disappointment: Datavault AI's Q1 GAAP EPS of -$0.09 misses expectations by $0.01, indicating challenges in profitability that could undermine investor confidence.
- Significant Revenue Growth: Despite a remarkable 442.9% year-over-year revenue increase to $3.42M, the figure fell short of market expectations by $16.58M, highlighting difficulties in expanding market share.
- Future Revenue Target: Datavault AI reiterates its $200 million revenue target for full-year 2026, which aligns with market consensus; however, the feasibility of achieving this goal remains uncertain given current financial performance.
- Market Reaction Anticipation: The earnings miss may lead investors to question the company's future growth potential, particularly in light of its plans to acquire CyberCatch to enhance cybersecurity capabilities.
See More
Datavault AI to Announce Q1 Earnings on May 15
- Earnings Announcement: Datavault AI is set to release its Q1 earnings on May 15 before market open, with a consensus EPS estimate of -$0.08, reflecting a 55.6% year-over-year improvement, indicating potential for enhanced profitability.
- Revenue Surge Expected: The company anticipates Q1 revenue of $20 million, representing a staggering 3074.6% year-over-year increase, which highlights Datavault AI's strong performance in market demand and product acceptance.
- Positive Market Sentiment: As the earnings report approaches, investor interest in Datavault AI is rising, likely leading to stock price volatility, especially after the company raised its revenue guidance, boosting market confidence in its future growth.
- Strategic Acquisition: Datavault AI plans to acquire CyberCatch in an all-stock deal to strengthen its capabilities in AI and quantum-resistant cybersecurity, a move that not only expands its product line but also enhances the company's competitive position in the market.
See More
